No. The number crunching boneheads don't distinguish between DRUG trials and STEM cells.
It is delusional to assert that the outcome of stage 3 is a NO. If it were, the FDA would never agree to it.
Stop pretending it's all logical outcomes. Teva has overreacted on the basis of their obviously poor decisionmaking on DRUG trials, and they've compounded this bad decisionmaking with a worse call.
Quite frankly, I'm glad they did as we now have the IP clear of them. (Sweating on this a bit aren't you?)
No. The number crunching boneheads don't distinguish between...
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.0¢ |
Change
-0.005(0.54%) |
Mkt cap ! $1.050B | |||
| Open | High | Low | Value | Volume |
| 92.0¢ | 92.5¢ | 91.5¢ | $1.133M | 1.233M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 151980 | 91.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.0¢ | 29989 | 2 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |